Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01IDE
|
||||
Former ID |
DIB014877
|
||||
Drug Name |
E-5324
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Discontinued in Phase 2 | [545733] | ||
Company |
Eisai Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C26H34N4O2
|
||||
Canonical SMILES |
n1c(c(n(c1)CCCOc1c(NC(=O)NCCCC)c(ccc1)C)CC)c1ccccc1
|
||||
CAS Number |
CAS 141799-76-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Liver carboxylesterase | Target Info | Modulator | [533828] | |
KEGG Pathway | Drug metabolism - other enzymes | ||||
Metabolic pathways | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.